IPO Announced
Eikon Therapeutics IPO
US$381m raised
Lodged 4 Feb 2026 · NASDAQ: EIKN · US$18.00 per share
Advisers
Lead managers
- Legal adviser
- Issuer
- Eikon Therapeutics
- Issuer based in
- United States
- Sector
- Oncology
- Tags
- Oncology, Biotech, Drug Development
Similar deals
- Parabilis Medicines IPO Jun 2026 · US$670m · Biotech
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Remix Therapeutics placement Jun 2026 · US$100m · Biotech
Sources
- 5 Feb 2026 Final IPO prospectus (424B4), Eikon Therapeutics, Inc. sec.gov
- 6 Feb 2026 Eikon Therapeutics $381 million IPO davispolk.com





